The AHA submitted comments June 26 to the House Ways and Means Subcommittee on Health for a hearing about improving value-based care. The AHA shared principles Congress should consider when designing alternative payment models to make participation more attractive for potential participants. Those principles include providing an adequate on-ramp and glidepath to transition to risk; including adequate risk adjustment; allowing voluntary participation and flexible design; balancing risk versus reward; and establishing guardrails to ensure participants don't compete against themselves when they achieve optimal cost savings and outcomes, among others. 

Additionally, the AHA was critical of the Centers for Medicare & Medicaid Services' newly proposed Transforming Episode Accountability Model — a mandatory bundled payment model — and suggested CMS make participation voluntary along with a host of other changes. The AHA also questioned design elements of CMS’ proposed Increasing Organ Transplant Access model, a mandatory payment model for kidney transplants. 

Headline
The Department of Health and Human Services Administration for Community Living has launched the first phase of its Health at Home Challenge, a competition to…
Headline
The AHA shared the following statement with the media in response to a report released May 7 by Families USA.   “This report is long on rhetoric and…
Headline
The Centers for Medicare & Medicaid Services announced May 6 that it will provide access to certain glucagon-like peptide-1 (GLP-1) medications to eligible…
Headline
The Centers for Medicare & Medicaid Services has begun collecting private payor rate data through its Fee-for-Service Data Collection System Clinical Lab…
Headline
Sens. Chuck Grassley, R-Iowa, and Michael Bennet, D-Colo., April 30 introduced the Rural Community Hospital Demonstration Reauthorization Act, legislation that…
Headline
The Centers for Medicare & Medicaid Services and the Food and Drug Administration April 23 announced a new pathway to expedite access to certain FDA-…